Restore Mind Medicine

Comparative Performance Company Mind Medicine (MindMed) Inc. SPDR S&P Biotech ETF Compass Pathways Plc. Cybin Inc. GH Research Plc ATAI Life Sciences NV Seelos Therapeutics Inc. Numinus Wellness Inc. Relmada Therapeutics Inc. Revive Therapeutics Ltd. Source: Data from Refinitiv. See [1], [2] June 8 2021 $55.65 $133.46 $36.21 $1.78 $19.25 $19.45 $3.30 $.94 $30.37 $.44 December 31 2021 $20.70 (-62%) $111.96 (-16%) $22.10 (-39%) $1.50 (-16%) $23.33 (21%) $7.63 (-61%) $1.63 (-51%) $.53 (-44%) $22.53 (-26%) $.34 (-23%) December 31 2022 $2.20 (-96%) $83.00 (-38%) $8.03 (-78%) $.42 (-76%) $9.72 (-50%) $2.66 (-86%) $.68 (-79%) $.185 (-80%) $3.49 (-89%) $.115 (-74%) April 14 2023 $3.06 (-95%) $78.19 (-41%) $9.94 (-73%) $.39 (-78%) $8.06 (-58%) $1.88 (-86%) $.78 (-76%) $.14 (-85%) $2.71 (-91%) $.05 (-89%) MindMed's Relative Performance From June 2021 -92% -82% -77% -88% -64% -79% -67% -44% -55% 8

View entire presentation